Dong-A Pharmaceutical
Company Details
Status: Private
Employees: 1,001-10,000
Location:
Seoul, Korea
Type:
sample
Technology:
sample
sample
sample
sample
sample
sample
sample
sample
About: Dong-A ST is a company established in March 2013 following the restructuring of the former Dong-A Pharmaceutical into a holding company.
Our company focuses on the development and sale of specialized pharmaceuticals (ETC) and is dedicated to the philosophy of "Our company's social contribution is in new drug development." With state-of-the-art research facilities such as the Yongin Research Center established in 1977 and the completion of the Songdo Research Center in 2021, Dong-A ST has been striving for innovative global new drug development with excellent research and development capabilities.
For many years, by consistently investing more than 10% of its revenue in R&D, we have successfully developed multiple proprietary novel drugs, including Stillen, Zydena, Motilitone, Sivextro, and Suganon/Sugamet.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Dong-A Pharmaceutical | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.